Institutional investors purchased a net $10.8 million shares of MNKD during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 25.71% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BEACH POINT CAPITAL MANAGEMENT L... Bought 1.9 Million shares of Mannkind Corp
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 1.9 Million shares of Mannkind Corp
CAPITAL FUND MANAGEMENT SA Bought 1.6 Million shares of Mannkind Corp